Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation

PURPOSE: Recent reports indicate that refractory central nervous system (CNS) metastases of non-small cell lung cancer (NSCLC) are improved by high-dose gefitinib or erlotinib administration. We describe a Japanese woman with NSCLC and CNS metastases who was resistant to 75 mg daily erlotinib, but t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Togashi, Yosuke, Masago, Katsuhiro, Fukudo, Masahide, Tsuchido, Yasuhiro, Okuda, Chiyuki, Kim, Young Hak, Ikemi, Yasuaki, Sakamori, Yuichi, Mio, Tadashi, Katsura, Toshiya, Mishima, Michiaki
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2011
Teme:
Short Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3180562/
https://ncbi.nlm.nih.gov/pubmed/21681573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1691-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki